Literature DB >> 27884595

Melatonin: Protection against age-related cardiac pathology.

Gaia Favero1, Lorenzo Franceschetti1, Barbara Buffoli1, Mohammed H Moghadasian2, Russel J Reiter3, Luigi F Rodella1, Rita Rezzani4.   

Abstract

Aging is a complex and progressive process that involves physiological and metabolic deterioration in every organ and system. Cardiovascular diseases are one of the most common causes of mortality and morbidity among elderly subjects worldwide. Most age-related cardiovascular disorders can be influenced by modifiable behaviours such as a healthy diet rich in fruit and vegetables, avoidance of smoking, increased physical activity and reduced stress. The role of diet in prevention of various disorders is a well-established factor, which has an even more important role in the geriatric population. Melatonin, an indoleamine with multiple actions including antioxidant properties, has been identified in a very large number of plant species, including edible plant products and medical herbs. Among products where melatonin has been identified include wine, olive oil, tomato, beer, and others. Interestingly, consumed melatonin in plant foods or melatonin supplementation may promote health benefits by virtue of its multiple properties and it may counteract pathological conditions also related to cardiovascular disorders, carcinogenesis, neurological diseases and aging. In the present review, we summarized melatonin effects against age-related cardiac alterations and abnormalities with a special focus on heart ischemia/reperfusion (IR) injury and myocardial infarction.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; Cardiac pathology; Heart ischemia/reperfusion injury; Melatonin; Myocardial infarction

Mesh:

Substances:

Year:  2016        PMID: 27884595     DOI: 10.1016/j.arr.2016.11.007

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  19 in total

1.  Network-based transcriptomic analysis reveals novel melatonin-sensitive genes in cardiovascular system.

Authors:  Ke Li; Fan Hu; Wan Xiong; Qing Wei; Fang-Fang Liu
Journal:  Endocrine       Date:  2019-04-15       Impact factor: 3.633

Review 2.  Melatonin-related signaling pathways and their regulatory effects in aging organisms.

Authors:  Mehmet Can Atayik; Ufuk Çakatay
Journal:  Biogerontology       Date:  2022-07-27       Impact factor: 4.284

Review 3.  Roles of melatonin and its receptors in cardiac ischemia-reperfusion injury.

Authors:  Kodchanan Singhanat; Nattayaporn Apaijai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2018-08-13       Impact factor: 9.261

4.  New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists.

Authors:  Jean A Boutin; Anne Bonnaud; Chantal Brasseur; Olivier Bruno; Nolwenn Lepretre; Peter Oosting; Sophie Coumailleau; Philippe Delagrange; Olivier Nosjean; Céline Legros
Journal:  Int J Mol Sci       Date:  2017-06-23       Impact factor: 5.923

Review 5.  Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

Review 6.  Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function.

Authors:  Iacopo Gesmundo; Tania Villanova; Dana Banfi; Giacomo Gamba; Riccarda Granata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-03       Impact factor: 5.555

Review 7.  Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?

Authors:  Zukiswa Jiki; Sandrine Lecour; Frederic Nduhirabandi
Journal:  Front Physiol       Date:  2018-05-17       Impact factor: 4.566

Review 8.  Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation.

Authors:  Gaia Favero; Lorenzo Franceschetti; Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Int J Endocrinol       Date:  2017-10-01       Impact factor: 3.257

Review 9.  Melatonin in Heart Failure: A Promising Therapeutic Strategy?

Authors:  Frederic Nduhirabandi; Gerald J Maarman
Journal:  Molecules       Date:  2018-07-22       Impact factor: 4.411

Review 10.  Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury.

Authors:  Dong Liu; Liqun Xu; Xiaoyan Zhang; Changhong Shi; Shubin Qiao; Zhiqiang Ma; Jiansong Yuan
Journal:  Aging Dis       Date:  2019-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.